Recruiting

Observational Study

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT00488878

Conditions

Low Grade Ovarian Serous Adenocarcinoma

Malignant Ovarian Neoplasm

Ovarian Carcinoma

Primary Peritoneal Carcinoma

Primary Peritoneal Low Grade Serous Adenocarcinoma

Eligibility Criteria

Sex: Female

Age: 0+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Electronic Health Record Review

Study Details

Brief summary:

This study collects information to maintain a database on patients with low-grade ovarian or peritoneal tumors. Collecting information about the type of cancer and treatment, as well as details about follow-up care, may help researchers learn and better understand these tumor types and help develop better treatments for them.

Conditions

Low Grade Ovarian Serous Adenocarcinoma

Malignant Ovarian Neoplasm

Ovarian Carcinoma

Primary Peritoneal Carcinoma

Primary Peritoneal Low Grade Serous Adenocarcinoma

Study ID

NCT00488878

Start date

May 19, 2006

Status verified date

Aug, 2026

Completion date

May 1, 2035

Anticipated

Primary completion date

May 1, 2034

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Female

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Patients whose disease progressed to a higher-grade carcinoma since the time of original diagnosis:

  • Ovarian tumor of low malignant potential
  • Low-grade serous carcinoma of the ovary
  • Primary peritoneal tumor of low malignant potential
  • Low-grade serous carcinoma of the peritoneum
  • Psammocarcinoma

Study Design

Enrollment

2000 participants

Anticipated

Interventions and Outcome Measures

Arms

Observational (electronic health record review)

Patients' medical records are reviewed for retrospective and prospective data collection. Patients may also have residual tissue samples collected and stored.

Interventions

Biospecimen Collection

Patients' residual tissue samples are collected

Electronic Health Record Review

Medical records are reviewed

Primary outcome measure

  • Prospective and retrospective data collection on disease characterization, treatment, and outcomes [ Time Frame: Up to 28 years ]
  • Organization of clinical information [ Time Frame: Up to 28 years ]
  • Creation of a single data repository to integrate clinical information and research findings [ Time Frame: Up to 28 years ]

Central Contacts and Locations

Central contacts

Lisa Nathan

713-745-3837lcnathan@mdanderson.org

Locations

M D Anderson Cancer Center

Recruiting

Houston, Texas, United States, 77030

Contacts

David M. Gershenson

713-563-4535

Principal Investigator:

David M. Gershenson

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

Aug 10, 2026

Last verified

Aug, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-08-10.